Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRC07-523LS and PGT121.414.LS with ART in Acute HIV Infection
NCT05719441Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2024
- Primary completion
- Jul 2028
- Countries
- 3
01
Overview
A Phase 2 trial of VRC07-523LS, PGT121 in acute human immunodeficiency virus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2024; status: recruiting.
02
Drugs
VRC07-523LSPGT121
03
Conditions
acute human immunodeficiency virus infection
Beyond the preview
Go deeper on NCT05719441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05719441.